Publications

  1. Sharma P, Imsande KG, Vitriago A, Seibel M, Pritchett JC, Rudder B, Watson D, Beenken MJ, Tran LT, Larson SL, Flock C, Murphy CM, Puljas TL, Patten CA, Asiedu GB, Odedina FT, Lynch BA, Haddad TC. WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trial. BMJ Open. 2026 Jun 01; 16(6):e113154.
    View PubMed
  2. Sharma P, Kamath CC, Jeno SE, Breutzman EN, Brockman TA, Patten CA, Haddad TC, Pritchett JC. Barriers, Facilitators, and Attitudes Toward Telemedicine Adoption in Oncology: A Qualitative Study of Patients From Low-Broadband Areas. JCO Oncol Pract. 2026 Mar 20; OP2501155 [Epub ahead of print]
    View PubMed
  3. Parameswaran V, Tsung S, Zeng YB, Miller M, Pritchett J, Demaerschalk BM, Rosengaus L, Sharp C, Lee B, Shah S. Distance-stratified sociodemographic differences in telemedicine use in surgical oncology clinics at an academic medical center. NPJ Digit Med. 2026 Feb 14; 9 (1)
    View PubMed
  4. Pritchett JC, Sharma P, Huang M, Dholakia R, Brockman TA, Moriarty JP, Kamath CC, Ahn H, Decker PA, Jiang R, Ticku J, Khera N, Brewer LC, Tilburt JC, Borah BJ, Patten CA, Haddad TC. Impact of broadband availability and digital literacy on video telehealth use among cancer patients. NPJ Digit Med. 2026 Feb 3; 9 (1) Epub 2026 Feb 03
    View PubMed
  5. Prasad DK, McGary AK, Kosiorek HE, Pritchett JC, Ellis RL, Ruddy KJ, Haddad TC, Yousufuddin M. Retrospective Analysis of Long-term Impact of COVID-19 Pandemic on Mammographic Breast Cancer Screening. Mayo Clin Proc Innov Qual Outcomes. 2026 Feb; 10 (1):100680 Epub 2025 Dec 06
    View PubMed
  6. Sener U, Galloway T, Neth B, Uhm J, Kizilbash SH, Campian JL, Caron S, Breen WG, Lehrer E, Golembiewski E, Schultz S, Hughes H, Steinmetz S, Geyer S, Mead-Harvey C, Huebert C, Tauer W, Mason C, Burns TC, Pritchett J, Haddad T. Protocol for neuro-oncology anywhere 242: Pilot study evaluating telehealth and in-person assessments in patients with glioma receiving oral chemotherapy. Contemp Clin Trials Commun. 2026 Feb; 49:101593. Epub 2025 Dec 23.
    View PubMed
  7. Walker MR, Burton KA, Collazo-Irizarry DE, Swenson W, Pritchett JC, LoConte NK, Narayan AK. Challenges and Opportunities for Rural Multidisciplinary Lung Cancer Care. J Am Coll Radiol. 2025 Dec; 22 (12):1609-1617
    View PubMed
  8. Parameswaran V, Miller M, Pritchett J, Demaerschalk B, Hu Y, Tsung S, Zeng YB, Rosengaus L, Sharp C, Lee B, Shah S. Telemedicine Trends in Ambulatory Surgical Oncology: A Five-Year Analysis of Visit Volume and Utilization at a High-Volume Academic Center. Ann Surg Oncol. 2025 Sep; 32 (9):6829-6837 Epub 2025 June 11
    View PubMed
  9. Parameswaran V, Miller M, Pritchett J, Demaerschalk B, Hu Y, Tsung S, Zeng YB, Rosengaus L, Sharp C, Lee B, Shah S. ASO Visual Abstract: Telemedicine Trends in Ambulatory Surgical Oncology-A Five-Year Analysis of Visit Volume and Utilization at a High-Volume Academic Center. Ann Surg Oncol. 2025 Jun 14 Epub 2025 June 14
    View PubMed
  10. Huey RW, Pritchett JC, Vokinger KN, Swenson W, Haddad TC, Adelson K. Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences. Am Soc Clin Oncol Educ Book. 2025 Jun; 45 (3):e473822 Epub 2025 June 17
    View PubMed
  11. Sener U, Uhm J, Haddad T, Pritchett J. Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic. Curr Oncol Rep. 2024 Nov; 26 (11):1271-1276 Epub 2024 July 31
    View PubMed
  12. Kelpin S, Brockman TA, Decker PA, Young A, Boehmer K, Nguyen A, Kamath C, St Sauver J, Sinicrope PS, Sharma P, McCoy R, Allen S, Huang M, Pritchett J, Esterov D, Lampman M, Petersen C, Cheville A, Patten CA. Increasing digital equity to promote online smoking cessation program engagement among rural adults: a randomized controlled pilot trial. Commun Med (Lond). 2024 Oct 8; 4 (1):194 Epub 2024 Oct 08
    View PubMed
  13. Desai A, Smith CJ, Pritchett JC, Leventakos K, West HJ. Examining crossover and postprotocol therapies in first-line immunotherapy trials in non-small cell lung cancer. Cancer. 2024 Aug 15; 130 (16):2807-2811 Epub 2024 Feb 14
    View PubMed
  14. Haemmerle R, Paludo J, Haddad TC, Pritchett JC. The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation. Curr Oncol Rep. 2024 Jun; 26 (6):593-600 Epub 2024 Apr 23
    View PubMed
  15. Pritchett JC, Paludo JC, Borah BJ, Haddad TC. Remote patient monitoring to transform management of febrile neutropenia in cancer patients. NEJM Catalyst Innovations in Care Delivery. 2024; 5 (4)
  16. Desai A, Xiao A, Smith C, Jensen C, Pritchett J, Soefje S, Durani U, Go R, Scheckel C, Hematology Oncology Outcomes Research Group. Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020. Mayo Clin Proc. 2023 Dec; 98 (12):1767-1773
    View PubMed
  17. Pritchett JC, Borah BJ, Dholakia R, Moriarty JP, Ahn HH, Huang M, Khera N, Wilshusen L, Dronca RS, Ticku J, Leppin AL, Tilburt JC, Paludo J, Haddad TC. Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021. JCO Oncol Pract. 2023 Sep; 19 (9):750-758 Epub 2023 June 19
    View PubMed
  18. Yang ZZ, Kim HJ, Wu H, Tang X, Yu Y, Krull J, Larson DP, Moore RM, Maurer MJ, Pavelko KD, Jalali S, Pritchett JC, Mudappathi R, Wang J, Villasboas JC, Mondello P, Novak AJ, Ansell SM. T-cell phenotype including CD57(+) T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma. Blood Cancer J. 2023 Aug 18; 13 (1):124
    View PubMed
  19. Anagnostou T, Yang ZZ, Jalali S, Kim HJ, Larson DP, Tang X, Yu Y, Pritchett JC, Bisneto JV, Price-Troska TL, Mondello P, Novak AJ, Ansell SM. Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma. Leukemia. 2023 Jul; 37 (7):1485-1498 Epub 2023 Apr 28
    View PubMed
  20. Pritchett JC, Patt D, Thanarajasingam G, Schuster A, Snyder C. Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity. Am Soc Clin Oncol Educ Book. 2023 Jun; 43:e390678
    View PubMed
  21. Haddad TC, Coffey JD, Deng Y, Glasgow AE, Christopherson LA, Sangaralingham LR, Bell SJ, Shah VP, Pritchett JC, Orenstein R, Speicher LL, Maniaci MJ, Ganesh R, Borah BJ. Impact of a High-Risk, Ambulatory COVID-19 Remote Patient Monitoring Program on Utilization, Cost, and Mortality. Mayo Clin Proc. 2022 Dec; 97(12):2215-2225. Epub 2022 Sep 06.
    View PubMed
  22. Desai AP, Scheckel CJ, Soderberg LC, Jensen CJ, Orme JJ, Tella SH, Kommalapati A, Pritchett JC, Khera N, Mahipal A, Go RS, Mayo Clinic Hematology and ONcology Outcomes Research (HONOR) Group. Economic Cost and Sustainability of Oral Therapies in Precision Oncology. JCO Oncol Pract. 2022 Aug; 18(8):e1247-e1254. Epub 2022 May 26.
    View PubMed
  23. Patten C, Brockman T, Kelpin S, Sinicrope P, Boehmer K, St Sauver J, Lampman M, Sharma P, Reinicke N, Huang M, McCoy R, Allen S, Pritchett J, Esterov D, Kamath C, Decker P, Petersen C, Cheville A. Interventions for Increasing Digital Equity and Access (IDEA) among rural patients who smoke: Study protocol for a pragmatic randomized pilot trial. Contemp Clin Trials. 2022 Aug; 119:106838 Epub 2022 June 25
    View PubMed
  24. Pritchett JC, Yang ZZ, Kim HJ, Villasboas JC, Tang X, Jalali S, Cerhan JR, Feldman AL, Ansell SM. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia. 2022 Jan; 36 (1):165-176 Epub 2021 July 06
    View PubMed
  25. Sharma P, Patten CA, Tilburt JC, Cheville AL, Pritchett JC, Brewer LC, White RO, Kelpin SS, Albertie M, Brockman TA, Doubeni CA. Development and initial cognitive testing of the Digital Equity Screening Tool (DEST): Community participatory approach to assessing digital inequality. J Clin Transl Sci. 2022; 6 (1):e117 Epub 2022 Aug 25
    View PubMed
  26. Pritchett JC, Haddad TC. Avoiding the "Faux Equalizer". Mayo Clin Proc. 2021 Dec; 96 (12):2963-2965 Epub 2021 Oct 30
    View PubMed
  27. Pritchett JC, Borah BJ, Desai AP, Xie Z, Saliba AN, Leventakos K, Coffey JD, Pearson KK, Speicher LL, Orenstein R, Virk A, Ganesh R, Paludo J, Halfdanarson TR, Haddad TC. Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO Oncol Pract. 2021 Sep; 17 (9):e1293-e1302 Epub 2021 June 04
    View PubMed
  28. Wu H, Tang X, Kim HJ, Jalali S, Pritchett JC, Villasboas JC, Novak AJ, Yang ZZ, Ansell SM. Expression of KLRG1 and CD127 defines distinct CD8(+) subsets that differentially impact patient outcome in follicular lymphoma. J Immunother Cancer. 2021 Jul; 9 (7)
    View PubMed
  29. Pritchett J, Ansell S. Immunologic Treatment Strategies in Mantle Cell Lymphoma: checkpoint inhibitors, and CAR-T Cells, and BiTE Molecules Annals of Lymphoma. 2019.
  30. Phan TL, Pritchett JC, Leifer C, Zerr DM, Koelle DM, Di Luca D, Lusso P. HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018 Dec; 53 (12):1508-1517 Epub 2018 May 24
    View PubMed
  31. Eliassen E, Lum E, Pritchett J, Ongradi J, Krueger G, Crawford JR, Phan TL, Ablashi D, Hudnall SD. Human Herpesvirus 6 and Malignancy: A Review. Front Oncol. 2018; 8:512 Epub 2018 Nov 13
    View PubMed
  32. Pritchett JC, Green JS, Thomm AM, Knox KK, Verneris MR, Lund TC. CD4+ T Cells Coexpressing CD134 (OX40) Harbor Significantly Increased Levels of Human Herpesvirus 6B DNA Following Umbilical Cord Blood Transplantation. J Infect Dis. 2016 Dec 15; 214 (12):1911-1915 Epub 2016 Oct 04
    View PubMed
  33. Stefanski HE, Thibert KA, Pritchett J, Prusty BK, Wagner JE, Lund TC. Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two Children. Pediatrics. 2016 Jan; 137 (1) Epub 2015 Dec 17
    View PubMed
  34. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Hollsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol. 2014 May; 159 (5):863-70 Epub 2013 Nov 06
    View PubMed
  35. Pantry SN, Medveczky MM, Arbuckle JH, Luka J, Montoya JG, Hu J, Renne R, Peterson D, Pritchett JC, Ablashi DV, Medveczky PG. Persistent human herpesvirus-6 infection in patients with an inherited form of the virus. J Med Virol. 2013 Nov; 85 (11):1940-6 Epub 2013 July 25
    View PubMed
  36. Arbuckle JH, Pantry SN, Medveczky MM, Prichett J, Loomis KS, Ablashi D, Medveczky PG. Mapping the telomere integrated genome of human herpesvirus 6A and 6B. Virology. 2013 Jul 20; 442 (1):3-11 Epub 2013 May 04
    View PubMed
  37. Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2013 Apr; 48 (4):574-80 Epub 2012 Sept 24
    View PubMed
  38. Dagna L, Pritchett JC, Lusso P. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol. 2013 Mar; 8 (3):273-287
    View PubMed
  39. Montoya JG, Neely MN, Gupta S, Lunn MR, Loomis KS, Pritchett JC, Polsky B, Medveczky PG. Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction. J Clin Virol. 2012 Sep; 55 (1):40-5 Epub 2012 July 05
    View PubMed
  40. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012 May; 22 (3):144-55 Epub 2011 Nov 04
    View PubMed
  41. Pritchett JC, Nanau RM, Neuman MG. The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation. Int J Hepatol. 2012; 2012:723062 Epub 2012 May 16
    View PubMed